← Back to headlines
Eli Lilly and InSilico Announce AI Drug Discovery Deal
Eli Lilly has struck a deal with InSilico, leveraging artificial intelligence for drug discovery in a move to accelerate pharmaceutical development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
